Table 2.
Inhibition of fusion mediated by HPIV3 or RSV F
Peptide | HPIV3 IC50 (μM) | RSV IC50 (μM) |
---|---|---|
RSV HRC–PEG4–Chol | >10 | 3.05±1.27 |
VIQKI–PEG4–Chol | 0.02±0.04 | 1.44±0.64 |
VIQKI–PEG24–Chol | 0.10±0.08 | 3.31±1.65 |
Inhibition of fusion mediated by HPIV3 or RSV F
Peptide | HPIV3 IC50 (μM) | RSV IC50 (μM) |
---|---|---|
RSV HRC–PEG4–Chol | >10 | 3.05±1.27 |
VIQKI–PEG4–Chol | 0.02±0.04 | 1.44±0.64 |
VIQKI–PEG24–Chol | 0.10±0.08 | 3.31±1.65 |